Australia's Monash IVF continues to increase its market share - Jefferies

Monash IVF

28/08/2022 20:45

** Jefferies says that in FY22, Monash IVF Group's  MVF.AX 
Australian fresh cycles market share increased by about 20 basis
points on pcp, as a result of market share gains in South
Australia, Queensland, and New South Wales; maintains 'buy'
rating, PT of A$1.25  
    ** Australian assisted reproductive services provider fell
as much as 2.9% on Friday after posting a full-year net profit
attributable of A$22.1 mln ($15.23 mln), down 4%  urn:newsml:reuters.com:*:nFWN3012C8 
    ** Estimates 2.5% Australian Assisted Reproductive Services
(ARS) market growth in FY23 due to on going changes in the
community perception of IVF, and we continue to expect growth
over the longer team - Jefferies
    ** Brokerage says MVF is maintaining its long-term market
growth expectations of 2-3% pa
    ** Five of five analysts rate the stock "buy" or higher;
their median PT is A$1.24 – Refinitiv data
    ** Stock has fallen 5.2% this year


($1 = 1.4510 Australian dollars)

 (Reporting by Jaskiran Singh in Bengaluru)
 ((Jaskiran.Singh@thomsonreuters.com;))